• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done?

作者信息

Granger Christopher B

出版信息

Circulation. 2006 Dec 5;114(23):2432-3. doi: 10.1161/CIRCULATIONAHA.106.666248.

DOI:10.1161/CIRCULATIONAHA.106.666248
PMID:17146002
Abstract
摘要

相似文献

1
Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done?化疗所致心肌病的预测与预防：能否实现？
Circulation. 2006 Dec 5;114(23):2432-3. doi: 10.1161/CIRCULATIONAHA.106.666248.
2
Anthracycline cardiotoxicity in children.儿童蒽环类药物心脏毒性
N Engl J Med. 2004 Jul 8;351(2):120-1. doi: 10.1056/NEJMp048113.
3
Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition.通过血管紧张素转换酶抑制预防高危患者高剂量化疗引起的心脏毒性。
Circulation. 2006 Dec 5;114(23):2474-81. doi: 10.1161/CIRCULATIONAHA.106.635144. Epub 2006 Nov 13.
4
Pharmacologic prevention of anthracycline-induced cardiomyopathy.蒽环类药物诱导的心肌病的药物预防
Cardiol Rev. 2009 Sep-Oct;17(5):243-52. doi: 10.1097/CRD.0b013e3181b8e4c8.
5
Exposure to anthracyclines during childhood causes cardiac injury.儿童时期接触蒽环类药物会导致心脏损伤。
Semin Oncol. 2006 Jun;33(3 Suppl 8):S8-14. doi: 10.1053/j.seminoncol.2006.04.019.
6
Strategies for reduction of anthracycline cardiac toxicity.降低蒽环类药物心脏毒性的策略。
Semin Oncol. 1998 Oct;25(5):525-37.
7
Anthracycline-induced cardiomyopathy.蒽环类药物诱导的心肌病。
Postgrad Med. 2008 Nov;120(4):67-72. doi: 10.3810/pgm.2008.11.1940.
8
[Cardioxan--a drug of prevention of anthracycline-related cardiotoxicity in pediatric oncology].[卡地氧（Cardioxan）——小儿肿瘤学中预防蒽环类药物相关心脏毒性的一种药物]
Vopr Onkol. 2002;48(1):110-2.
9
Doxorubicin-induced cardiomyopathy.阿霉素诱导的心肌病。
N Engl J Med. 1999 Feb 25;340(8):654-5.
10
Dexrazoxane for the prevention of cardiomyopathy in anthracycline treated pediatric cancer patients.右丙亚胺用于预防蒽环类药物治疗的儿童癌症患者的心肌病。
Pediatr Blood Cancer. 2005 Jun 15;44(7):584-8. doi: 10.1002/pbc.20358.

引用本文的文献

1
Understanding the Mechanisms of Chemotherapy-Related Cardiotoxicity Employing hiPSC-Derived Cardiomyocyte Models for Drug Screening and the Identification of Genetic and Epigenetic Variants.利用人诱导多能干细胞衍生的心肌细胞模型进行药物筛选以及鉴定基因和表观遗传变异，以了解化疗相关心脏毒性的机制。
Int J Mol Sci. 2025 Apr 23;26(9):3966. doi: 10.3390/ijms26093966.
2
Multi-lineage heart-chip models drug cardiotoxicity and enhances maturation of human stem cell-derived cardiovascular cells.多谱系心脏芯片可模拟药物心脏毒性并促进人干细胞衍生心血管细胞的成熟。
Lab Chip. 2024 Feb 13;24(4):869-881. doi: 10.1039/d3lc00745f.
3
The Imbalance of p53-Park7 Signaling Axis Induces Iron Homeostasis Dysfunction in Doxorubicin-Challenged Cardiomyocytes.
p53-Park7 信号轴失衡导致阿霉素损伤的心肌细胞中铁离子稳态失衡。
Adv Sci (Weinh). 2023 May;10(15):e2206007. doi: 10.1002/advs.202206007. Epub 2023 Mar 26.
4
RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy.RARG 变异可预测多柔比星所致心脏毒性，并确定一种心脏保护性疗法。
Cell Stem Cell. 2021 Dec 2;28(12):2076-2089.e7. doi: 10.1016/j.stem.2021.08.006. Epub 2021 Sep 15.
5
Statin Use Can Attenuate the Decline in Left Ventricular Ejection Fraction and the Incidence of Cardiomyopathy in Cardiotoxic Chemotherapy Recipients: A Systematic Review and Meta-Analysis.他汀类药物的使用可减轻接受心脏毒性化疗患者的左心室射血分数下降及心肌病发生率：一项系统评价和荟萃分析
J Clin Med. 2021 Aug 22;10(16):3731. doi: 10.3390/jcm10163731.
6
Cardiovascular and Cancer Risk: The Role of Cardio-oncology.心血管与癌症风险：心脏肿瘤学的作用。
J Adv Pract Oncol. 2018 Mar;9(2):160-176. Epub 2018 Mar 1.
7
Imaging doxorubicin and polymer-drug conjugates of doxorubicin-induced cardiotoxicity with bispecific anti-myosin-anti-DTPA antibody and Tc-99m-labeled polymers.用双特异性抗肌球蛋白-抗二乙三胺五乙酸抗体和锝-99m标记的聚合物成像多柔比星及多柔比星聚合物药物偶联物诱导的心脏毒性。
J Nucl Cardiol. 2019 Aug;26(4):1327-1344. doi: 10.1007/s12350-018-1190-2. Epub 2018 Feb 1.
8
Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity.人诱导多能干细胞衍生的心肌细胞重现了乳腺癌患者对阿霉素诱导的心脏毒性的易感性。
Nat Med. 2016 May;22(5):547-56. doi: 10.1038/nm.4087. Epub 2016 Apr 18.
9
Patient-Specific Pluripotent Stem Cells in Doxorubicin Cardiotoxicity: A New Window Into Personalized Medicine.多柔比星心脏毒性中的患者特异性多能干细胞：个性化医疗的新窗口。
Prog Pediatr Cardiol. 2014 Dec 1;37(1-2):23-27. doi: 10.1016/j.ppedcard.2014.10.006.
10
Attenuation of doxorubicin-induced cardiotoxicity by mdivi-1: a mitochondrial division/mitophagy inhibitor.Mdivi-1 抑制线粒体分裂/自噬减轻阿霉素诱导的心脏毒性。
PLoS One. 2013 Oct 17;8(10):e77713. doi: 10.1371/journal.pone.0077713. eCollection 2013.